19 June 2024
Unaudited Results for the 52 weeks ended 1 April 2024 2024 2023 52 weeks 53 weeks1 % Unaudited results £m £m change …
18 June 2024
M.P. EVANS GROUP PLC (“Group” or “M.P. Evans”) Share buyback programme The board of directors of M.P. Evans (“Board“) is pleased to announce that it will commence…
Update on the CAPItello-290 Phase III trial for Truqap plus chemotherapy in advanced or metastatic triple-negative breast cancer The CAPItello-290 Phase III trial for Truqap (capivasertib) in combination…
17 June 2024
Hansa Investment Company Limited Annual Report: Year ended 31 March 2024 Chairman’s report Dear Shareholder Shareholder Returns It is very pleasing to report an…
17 June 2024 MONTANARO UK SMALLER COMPANIES INVESTMENT TRUST PLC 2024 ANNUAL RESULTS ANNOUNCEMENT AND NOTICE OF ANNUAL GENERAL MEETING Montanaro UK Smaller Companies…
17 June 2024 Imfinzi plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer Approval based on DUO-E trial results,…
14 June 2024
14 June 2024 Crest Nicholson Holdings plc (“Crest Nicholson”) Response to possible offer announcement by Bellway p.l.c. (“Bellway”) The Board of Crest Nicholson notes the…
M.P. EVANS GROUP PLC (“Group” or “M.P. Evans”) ANNUAL GENERAL MEETING The annual general meeting of M.P. Evans Group PLC, a producer of sustainable…